SMS-based intervention in type 2 diabetes: clinical trial in Senegal

2018 ◽  
Vol 4 (3) ◽  
pp. 142-146 ◽  
Author(s):  
Matthieu Wargny ◽  
Line Kleinebreil ◽  
Said Norou Diop ◽  
Maïmouna Ndour-Mbaye ◽  
Mady Ba ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Low Income ◽  
Short Message ◽  
Middle Income ◽  
Mobile Telephones ◽  
Message Service ◽  
The Difference ◽  
Medical Teams

ObjectiveSince 2014 Senegal has benefited from regular awareness-raising Short Message Service (SMS) campaigns (Be He@lthy, Be Mobile initiative) directed at people who have signed up, for free, to the ‘mDiabète’ programme. We report on an evaluation of its impact on diabetes control.DesignThe clinical trial was designed to send daily SMS during 3 months to people with type 2 diabetes. Due to centre randomisation, SMS were sent from inclusion (M0) to month 3 (M3) to people in centre S and from M3 to month 6 (M6) to people in centre P.SettingMedical centre S in the northwestern suburbs of Dakar; centre P in Popenguine, 70 km south of Dakar.ParticipantsIn February 2017, people with type 2 diabetes were consecutively recruited in the two centres. Complete data were available from 186 of these people.Main outcome measuresHbA1c was measured in the two centres with the same assay throughout the study. The primary end point was the difference between centres for the change in HbA1c from M0 to M3. Secondary end points were the evolution of HbA1c in centres S and P between M3 and M6.ResultsThe HbA1c change from M0 to M3 in centre S was better than in centre P, with a median difference of −0.4%, quartiles (−1.0; 0.3) versus 0.2% (-0.5; 0.8), respectively (p=0.0038). HbA1c decreased over the 3 months after having stopped SMS in centre S and was confirmed in centre P. The campaign cost was €2.5 (US$3.1) per person.ConclusionsIn Senegal, SMS sending was associated with an improved glycaemic control in people with type 2 diabetes. As SMS has a high penetration in low-income, middle-income countries where medical resources are scarce, health interventions using mobile telephones should be developed to facilitate exchanges between people with diabetes and medical teams; this may reduce diabetes-related complications.

Coprevalence of type 2 diabetes mellitus and tuberculosis in low-income and middle-income countries: A systematic review

2018 ◽  
Vol 35 (1) ◽  
pp. e3066 ◽  
Author(s):  
Hannah Stowe McMurry ◽  
Emily Mendenhall ◽  
Aravind Rajendrakumar ◽  
Lavanya Nambiar ◽  
Srinath Satyanarayana ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Low Income ◽  
Middle Income ◽  
Middle Income Countries

scholarly journals Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Carlos K. H. Wong ◽  
Fang-Fang Jiao ◽  
Shing-Chung Siu ◽  
Colman S. C. Fung ◽  
Daniel Y. T. Fong ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Glucose Tolerance ◽  
Impaired Glucose Tolerance ◽  
Short Message Service ◽  
Short Message ◽  
Intervention Cost ◽  
Message Service ◽  
Sms Intervention

Aims. To investigate the costs and cost-effectiveness of a short message service (SMS) intervention to prevent the onset of type 2 diabetes mellitus (T2DM) in subjects with impaired glucose tolerance (IGT).Methods. A Markov model was developed to simulate the cost and effectiveness outcomes of the SMS intervention and usual clinical practice from the health provider’s perspective. The direct programme costs and the two-year SMS intervention costs were evaluated in subjects with IGT. All costs were expressed in 2011 US dollars. The incremental cost-effectiveness ratio was calculated as cost per T2DM onset prevented, cost per life year gained, and cost per quality adjusted life year (QALY) gained.Results. Within the two-year trial period, the net intervention cost of the SMS group was $42.03 per subject. The SMS intervention managed to reduce 5.05% onset of diabetes, resulting in saving $118.39 per subject over two years. In the lifetime model, the SMS intervention dominated the control by gaining an additional 0.071 QALY and saving $1020.35 per person. The SMS intervention remained dominant in all sensitivity analyses.Conclusions. The SMS intervention for IGT subjects had the superiority of lower monetary cost and a considerable improvement in preventing or delaying the T2DM onset. This trial is registered with ClinicalTrials.govNCT01556880.

Effectiveness of short message service-based intervention (SMS) on self-care in type 2 diabetes: A feasibility study

2016 ◽  
Vol 10 (4) ◽  
pp. 251-258 ◽  
Author(s):  
Maryam Peimani ◽  
Camelia Rambod ◽  
Maryam Omidvar ◽  
Bagher Larijani ◽  
Robabeh Ghodssi-Ghassemabadi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Feasibility Study ◽  
Short Message Service ◽  
Self Care ◽  
Short Message ◽  
Message Service

scholarly journals Sugar-sweetened beverage consumption in the early years and implications for type-2 diabetes: a sub-Saharan Africa context

2019 ◽  
Vol 78 (4) ◽  
pp. 547-553 ◽  
Author(s):  
Keiron Audain ◽  
Louis Levy ◽  
Basma Ellahi
Keyword(s):  
Type 2 Diabetes ◽  
Low Income ◽  
Health Care Systems ◽  
Early Years ◽  
Sub Saharan Africa ◽  
Low Income Countries ◽  
Middle Income ◽  
Sugary Drinks ◽  
Sub Saharan

This review aims to explore trends of early consumption of sugar-sweetened beverages (SSB) in sub-Saharan Africa (SSA), within the context of growing child and adolescent obesity and escalating type-2 diabetes prevalence. We explore efforts to mitigate these, drawing on examples from Africa and elsewhere. SSB, including carbonated drinks and fruit juices, play a contributory role in the development of obesity and associated non-communicable diseases (NCD). SSA is an attractive market for beverage companies owing to its rapid economic growth, growing middle class and youthful populations. SSB already contribute significantly to total sugar and energy consumption in SSA where a plethora of marketing techniques targeted at younger people are utilised to ensure brand recognition and influence purchasing and brand loyalty. Coupled with a general lack of nutrition knowledge or engagement with preventative health, this can lead to frequent consumption of sugary drinks at a young age. Public health efforts in many high income and some middle-income countries address increasing prevalence of obesity and type-2 diabetes by focusing on strategies to encourage reduction in sugar consumption via health policy and public education campaigns. However, similar efforts are not as developed or forthcoming in low-income countries. Health care systems across SSA are ill-prepared to cope with epidemic proportions of NCD, particularly when contextualised with the ongoing battle with infectious diseases. We conclude that greater efforts by governments and the nutrition community to educate the public on the health effects of increased and excessive consumption of SSB are necessary to help address this issue.

scholarly journals The Effect of Bread Enriched With Portulaca Oleracea on Metabolic Control Indices in Patients With Type 2 Diabetes: a Parallel Randomized Clinical Trial

2021 ◽  
Author(s):  
Mehri Delvarianzadeh ◽  
Abdorreza Mohammadi Nafchi ◽  
Leila Nouri ◽  
Ahmad Khosravi ◽  
Aisa Bahar ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Metabolic Control ◽  
Blood Sugar ◽  
Density Lipoprotein ◽  
Portulaca Oleracea ◽  
Significant Difference ◽  
Before And After ◽  
The Difference

Abstract Background: Diabetes is the most common chronic disease worldwide. Some herbs are used to control diabetes. Portulaca Oleracea is a type of plant that has essential fatty acid-rich leaves. Objectives: This study aimed to evaluate the effect of bread enriched with Portulaca Oleracea on metabolic control indices in patients with type 2.Methods: This parallel randomized controlled clinical trial was conducted on 104 patients with type 2 diabetes. Participants received bulk bread containing 10% Portulaca powder for 4 weeks (intervention group), the control group used their normal daily bread. At baseline and end of the study a 12 hours fasting and 2 hours later blood sample were collected to quantify plasma glucose levels and lipid profiles. The effectiveness of the intervention method was compared with the difference between the mean before and after the intervention (change score) in the two groups using t-test.Results: The results showed that after the intervention, a significant difference was found between Fasting blood sugar, cholesterol and high-density lipoprotein variables in intervention groups, but could not affect serum low-density lipoprotein, triglyceride levels, blood sugar and Glycated hemoglobin(HbA1C) It should be noted that the difference between the means of the two groups before and after the intervention indicates that there is a significant difference between the other groups except HbA1C. Conclusions: consumption of bread enriched with portulaca oleracea did have a significant impact on metabolic indices of diabetes and improvement lipid profile. It is recommended to use bread enriched with portulaca oleracea powder, areas where the staple food is bread.Trial registration in the Iranian clinical trial system with the code IRCT2011030309006010N1.

Sign in / Sign up

Export Citation Format

Share Document